Summary
Medicines & Healthcare products Regulatory Agency multi‑work‑package program to update regulation of software and AI as medical devices across the lifecycle, including qualification, pre‑market evidence, post‑market monitoring, and transparency.
Healthcare Implications
Signals evolving UK expectations for AI medical devices. Developers and National Health Service providers should track deliverables that affect submissions, labeling, and post‑market surveillance.